ALK inhibitor response in melanomas expressing EML4-ALK fusions and alternate ALK isoforms

Oncogenic ALK fusions occur in several types of cancer and can be effectively treated with ALK inhibitors; however, ALK fusions and treatment response have not been characterized in malignant melanomas. Recently, a novel isoform of ALK (ALK(ATI)) was reported in 11% of melanomas but the response of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Couts, Kasey L., Bemis, Judson, Turner, Jacqueline A., Bagby, Stacey M., Murphy, Danielle, Christiansen, Jason, Hintzsche, Jennifer D., Le, Anh, Pitts, Todd M., Wells, Keith, Applegate, Allison, Amato, Carol, Multani, Pratik, Chow-Maneval, Edna, Tentler, John J., Shellman, Yiqun G., Rioth, Matthew J., Tan, Aik-Choon, Gonzalez, Rene, Medina, Theresa, Doebele, Robert C., Robinson, William A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5752582/
https://ncbi.nlm.nih.gov/pubmed/29054983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0472
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados